Aethlon Medical
AEMD
13 hedge funds and large institutions have $185K invested in Aethlon Medical in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
7% less funds holding
Funds holding: 14 → 13 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
45% less capital invested
Capital invested by funds: $334K → $185K (-$149K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| 1 |
CFN
Cordasco Financial Network
Naples,
Florida
|
+$58.9K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.46K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.46K |
Top Sellers
AEMD Hedge Fund Activity: Q3 2019 in Review
13 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2019, worth a combined $185K — down 45% from $334K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AEMD and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest buyer was Cordasco Financial Network, opening a new position worth an estimated $58.9K. The largest seller was Vanguard Group, cutting an estimated $52K.
- 13 institutional investors held Aethlon Medical (AEMD) as of Q3 2019, down from 14 in Q2 2019.
- Funds reported $185K of Aethlon Medical stock for Q3 2019, down 45% quarter-over-quarter.
- 3 funds opened new Aethlon Medical positions in Q3 2019 and 4 closed out, a net change of -1 holder.
- The largest Aethlon Medical buyer in Q3 2019 was Cordasco Financial Network, an estimated $58.9K added.
- The largest Aethlon Medical seller in Q3 2019 was Vanguard Group, an estimated $52K sold.
Based on aggregated 13F filings for Q3 2019.